Jagsonpal Pharmaceuticals Limited — Board Meeting, 27-04-2026: Outcome of Board Meeting

Jagsonpal Pharma's board reported standalone FY26 net profit of ₹43.08 Cr & Q4 net profit of ₹8.76 Cr. They also proposed a ₹4/share final dividend. Separately, shareholders approved a ₹40 Cr share buy-back at ₹250/share.